Filing Flows › Conmed (CNMD) › Capital expenditures
Conmed (CNMD) capital expenditures by quarter
Conmed's capital expenditures were $2.7M in Q3 2026 (third quarter 2026), -9% from Q2 2026. Over the last 7 quarters it ranged from $2.7M (Q3 2026) to $5.7M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.7M | -9% | -48% |
| Q2 2026 | $2.9M | +1% | -49% |
| Q1 2026 | $2.9M | -43% | -23% |
| Q4 2025 | $5.1M | -1% | — |
| Q3 2025 | $5.2M | -9% | — |
| Q2 2025 | $5.7M | +52% | — |
| Q1 2025 | $3.8M | — | — |
Q3 2026 at a glance
Conmed, Q3 2026: revenue $336M (-0.7% year over year), operating margin 11.1%, net earnings $19.8M, operating cash flow $49.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Conmed's capital expenditures?
Conmed's capital expenditures were $2.7M in Q3 2026 (third quarter 2026), -9% from Q2 2026.
How has Conmed's capital expenditures changed?
Over the last 7 quarters it ranged from $2.7M (Q3 2026) to $5.7M (Q2 2025).